Solitary splenic metastases from head and neck cancer are rare. We report a 35-year-old male with nasal cavity cancer with metastasis to the cervical lymph nodes. The patient underwent three cycles of induction chemotherapy, followed by left medial maxillectomy with modified radical neck dissection and concurrent chemoradiotherapy with weekly cisplatin. After 7 months of a disease-free interval, positron-emission tomography showed a high uptake in the spleen, and a biopsy confirmed metastatic carcinoma. After four cycles of systemic chemotherapy with docetaxel and cisplatin, laparoscopic splenectomy was performed. This case highlights that solitary splenic metastasis, although rare, may occur with a locoregionally controlled head and neck cancer and could be treated with local and systemic treatment. (Korean J Med 2013;85:324-328) 
INTRODUCTION
Although the prevalence of splenic metastases seems to increase with the improvement of medical imaging techniques, it remains rare [1, 2] . Additionally, a solitary splenic lesion as a single site of metastasis from treated solid tumors is a rare occurrence [3] . In head and neck cancer, the lung, bone, and liver were the most common sites of distant metastases [4] . Distant metastasis in head and neck cancer has remained the major cause of mortality and treatment failure, despite better loco-regional control of the disease. Hence, evaluating systemic metastasis is critical. We report a rare case of head and neck cancer metastasizing to the spleen.
CASE REPORT
A 35-year-old male, who was a non-smoker and a social drinker, was presented to our center with a palpable neck mass. Computed tomography (CT) showed multiple enlarged cervical lymph nodes III, IV/V lymph node region for 6 weeks.
The patient was followed up 1 month after the completion of chemoradiotherapy, and then every 3 months thereafter. After 7 months of disease-free survival, whole-body PET-CT showed increased uptake in the spleen, and abdominal CT demonstrated a 2.5-cm slowly enhancing mass in the spleen without any notable findings in other organs, including the primary site (Fig. 2) . There was no splenomegaly or palpable mass in the abdomen, and the patient had no symptoms. Spleen needle biopsy was performed, the splenic nodule was consistent with metastatic carcinoma, and tumor cells were also positive for EBV-ISH (Fig. 3) . He received four cycles of systemic chemotherapy with docetaxel and cisplatin.
Follow-up abdominal CT revealed a decrease in size of the splenic metastasis; however, the response was stable disease.
Laparoscopic splenectomy was performed, and the specimen showed a tumor 1.8 × 1.5 × 1.3 cm in size and light gray, and there was no evidence of capsular invasion (Fig. 4) . Histological exami- -327 -bone marrow [4] . Once distant metastases have occurred, long-term survival is generally poor. The time interval between the diagnosis of distant metastases and death is less than 2 years in more than 90% of patients [4] .
Although the prevalence of splenic metastases seems to increase with the improvement of medical imaging techniques, it remains uncommon [1, 5] . Explanations proposed for the relative paucity of splenic metastasis have included (1) the sharp angle made by the splenic artery, which makes it difficult for tumor emboli to enter the spleen, (2) the absence of afferent lymphatics to bring the metastatic tumor to the spleen, and (3) antitumor activity due to a high concentration of lymphoid tissue in the spleen [1] . An autopsy of patients who died of head and neck cancer showed that, of the 832 patients autopsied, 387 were found to have histologically confirmed distant metastases at one or more sites, and 9% of them (35 patients) had splenic metastasis [5] . Only one case report to date has shown a solitary splenic metastasis from head and neck cancer [6] .
This case suggests that splenic metastasis, although rare, may occur with successfully treated head and neck cancer. In the present case, the lesion in the spleen was an isolated metastasis in a locoregionally controlled nasal cavity cancer, and the metastasis occurred after ~7 months of a disease-free interval. Patients with recurrent or metastatic disease, who are not surgical or radiation therapy candidates, are usually offered palliative options, and systemic chemotherapy has become the standard of care in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) [7] . The present case underwent systemic treatment initially because the lesion in the spleen was confirmed to be a metastasis by biopsy. reported that the 1-year survival rate and median survival after treatment of splenic metastasis in colorectal cancer were 86.6% and 66 months, respectively [10] . In our case, because the patient was young with a good performance status, local treatment for the splenic lesion was considered, and splenectomy was performed without complications.
Distant metastasis in head and neck cancer remains the major cause of mortality and treatment failure, despite better loco-regional control of the disease; therefore, it is crucial to evaluate the metastasis. Although rare, splenic metastasis of head and neck cancer does occur and should be considered for local and systemic treatment.
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